#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cardiac arrest Red blood cell abnormality Malignant fibrous histiocytoma Non-small cell lung cancer recurrent Isodicentric chromosome 15 syndrome Partial lipodystrophy Henoch-Schonlein purpura nephritis Metastatic gastric cancer C3 glomerulopathy Pericarditis Salivary gland cancer Thalassaemia beta Thymic carcinoma Hypomagnesaemia Familial hypertriglyceridaemia More trials…

    Learn about Rare Diseases

    KBG syndrome – Basic Information Wolfram syndrome Hereditary motor and sensory neuropathy – Treatment Metachromatic leukodystrophy – Diagnostics Hepatoblastoma – Diagnostics Osteosarcoma metastatic – Diagnostics Leiomyosarcoma – Diagnostics Undifferentiated sarcoma – Trials in Disease Hyperoxaluria Osteosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    L-Tryptophan Calcipotriol Macitentan Dronabinol Retinol Acetate Tiotropium Pegaspargase Daxdilimab Ngi226 Tramazoline Hydrochloride Fenfluramine Hydrochloride Dalbavancin Piracetam Pemetrexed Disodium Everolimus Bilastine Esketamine Hydrochloride Cabozantinib DIMENHYDRINATE Crizotinib More therapies…

    Learn about Your Condition

    Barrett's oesophagus Chronic hepatitis C Skin candida Oesophageal disorder Hypophosphatasia Abdominal pain Tympanic membrane hyperaemia Atrophic vulvovaginitis Leukocyte adhesion deficiency Syphilis Chordoma Cerebral amyloid angiopathy Cortisol abnormal Cryoglobulinaemia Stomatitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hopital Henri Mondor – 1 rue Gustave Eiffel

Hopital Henri Mondor – 1 rue Gustave Eiffel

51 Av Du Mal De Lattre De Tassigny, Creteil, 94000, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Clopidogrel
    • Milvexian
    • Prasugrel
    Austria Belgium Bulgaria Croatia Czechia Denmark +14

  • Study Comparing MK-4280A (Favezelimab and Pembrolizumab) with Chemotherapy for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hodgkin’s disease
    Investigated Drugs:
    • Favezelimab
    • Gemcitabine
    • Pembrolizumab
    Belgium Czechia France Germany Poland Spain +1

  • Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Andexanet Alfa
    • Milvexian
    • Apixaban
    Belgium Bulgaria Croatia Czechia Denmark Estonia +13

  • Study on Rifaximin for Delaying Hepatic Encephalopathy in Cirrhosis Patients

    Not recruiting

    3 1
    Investigated Drugs:
    • Rifaximin
    Belgium Bulgaria France Germany Hungary Italy +2

  • Study on the Long-Term Safety and Effectiveness of Amlitelimab for Adults with Moderate to Severe Atopic Dermatitis

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Amlitelimab
    Czechia Denmark France Germany Italy The Netherlands +2

  • Study on the Safety and Effectiveness of Deucravacitinib for Patients with Active Discoid and/or Subacute Cutaneous Lupus Erythematosus

    Not recruiting

    2 1
    Investigated Drugs:
    • Deucravacitinib
    France Germany Poland

  • Study Comparing Axicabtagene Ciloleucel and Standard Treatment for Adults with High-Risk Large B-Cell Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Axicabtagene Ciloleucel
    • Diphenhydramine
    • Mesna
    Austria France Germany Italy The Netherlands Portugal +1

  • Study on Azithromycin for Treating Chronic Sinusitis in Adults

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Chronic sinusitis
    • Sinusitis bacterial
    Investigated Drugs:
    • Azithromycin
    France

  • Study of PF-07220060 and Letrozole for Adults with HR-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Abemaciclib
    • Palbociclib
    • Pf-07220060 Monohydrate
    Belgium Bulgaria Czechia Denmark Finland France +10

  • Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Asundexian
    • Apixaban
    Austria Belgium Bulgaria Czechia Denmark Estonia +16
Previous Page
1 … 9 10 11

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!